CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 277 enrolled
Drug / intervention
Face-it Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03997773
NCT03997773N/ACompleted

Face-it: A Health Promotion Intervention for Women With Prior Gestational Diabetes and Their Families - A Randomised Controlled Trial

Steno Diabetes Center Copenhagen·interventional·Posted Jun 25, 2019·Updated Jul 12, 2024

In Brief

A clinical study evaluating Face-it Intervention for Gestational Diabetes and 2 related conditions. Completed, enrolled 277 participants across 3 sites.

Detailed Summary

This project focuses on evaluating a health promotion intervention among families where the mother has prior gestational diabetes mellitus (GDM) in the first year after delivery. The intervention focuses on the individual, family and health system levels. The aim is to increase quality of life and reduce the risk of type 2 diabetes among women with prior GDM and their families.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 25, 2019
Enrollment StartMay 16, 2019
Primary CompletionJun 6, 2023
Study CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 7.0 years ago

Interventions

Face-it Interventionbehavioral

The Face-it intervention is a health promotion intervention consisting of 3 major components: 1) active involvement of health visitors, 2) digital health technology and coaching, and 3) a structured cross-sectoral communication system in the healthcare system. The intervention will begin at time approx. 3 months (after the baseline data collection, i.e. 10-14 weeks postpartum), and continues until 12 months